key: cord-0914777-ahur9u5w
authors: Rodriguez, Adrian; Arrizabalaga, Maria; Fernandez-Baca, Victoria; Lainez, Maria Pilar; Al Nakeeb, Zaid; Garcia, Jose Daniel; Payeras, Antoni
title: Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of COVID-19 pandemic
date: 2021-02-27
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.02.104
sha: 21072fa56fc9ef6c4c966be768fde1e8f62dc93f
doc_id: 914777
cord_uid: ahur9u5w

Objective To estimate the SARS-CoV-2 antibody seroprevalence in HCWs at a secondary hospital in Mallorca, Spain. Methods All HCWs received an e-mail inviting them to take part in the study. Participants had a nasopharyngeal swab test performed for reverse transcription quantitative polymerase chain reaction (RT-qPCR) and serological tests to detect SARS-CoV-2 antibodies (primary study). Additionally, they were invited to complete a questionnaire on their exposure to COVID-19 individuals and their COVID-19-related symptoms (secondary study). Prevalence of antibodies (IgG, IgM or both) and 95% confidence intervals (CIs) were calculated. Results Seventy nine percent of the hospitalʼs HCWs (N = 2210) took part in the primary study. Antibodies were detected in 61 participants, a prevalence of 2.8% (95% CI: 2.5-3.1). The prevalence was slightly higher in nurses (3.4%), registrars (3.9%), and wardens (3.4%). Thirty nine percent of the primary study participants completed the secondary study questionnaire. Those with positive antibody test results had been in closer contact with COVID-19 individuals (60% vs 92%; p < 0.001). Conclusion After the first wave of the COVID-19 pandemic in Spain, the seroprevalence of SARS-CoV-2 antibodies in our secondary hospital HCWs was around 2.8%, which is slightly higher than the seroprevalence in the general population in our region. We believe it would be advisable to perform further seroprevalence studies during the second wave of the epidemic.

COVID-19 (coronavirus disease, 2019) is a novel viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in December 2019 in Wuhan, China (Zhu N. et al, 2020) . Due to the alarming levels of spread, disease severity, number of affected countries, and number of deaths, the World Health Organization (WHO) declared COVID-19 a pandemic on 11 th March 2020 (World Health Organization, 2020). To date (15 h February 2021), there has been more that 106 million confirmed cases and more than two million deaths worldwide (European Centre for Disease J o u r n a l P r e -p r o o f Prevention and control, 2020) . Spain has been one of the most affected countries (Instituto de Salud Carlos III, 2020) .

Most of the available data on SARS-CoV-2 infection are from symptomatic patients, with symptoms that vary from mild symptomatology, such as fever, cough, diarrhoea, or anosmia, to severe pneumonia, respiratory distress, and death (Martin-Sanchez F.J. et al, 2020; Aguila E.J.T. et al, 2020; Vargas-Gandica J. et al, 2020; Guan W. et al, 2020) . However, it has been demonstrated that some patients with a SARS-CoV-2 infection can remain asymptomatic. In these cases, seroprevalence studies can be useful to determine the proportion of individuals who have antibodies against SARS-CoV-2, and can be used to estimate the actual number of individuals who have been infected. Several population-based studies in this line of research estimating the burden of SARS-CoV-2 infection in France, Switzerland, and Spain have been published (Salje H. et al, 2020; Stringhini S. et al, 2020; Pollan M. et al, 2020) . In the latter, in a sample of more than 61 000 participants across Spain, the estimated seroprevalence determined by immunoassay was 4.6% (95% CI: 4.3-5.0) (Pollan M. et al, 2020) . In the Balearic Islands, one of the regions in Spain with fewer cases during the first wave of the epidemic, probably due to an islands effect, mean seroprevalence was 1.8% (Pollan M. et al, 2020) . This study was performed at the end of April and beginning of May, which is considered the end of the first wave of the pandemic in Spain (Pollan M. et al, 2020) .

Hospital healthcare workers (HCWs) are a population particularly at risk of infection since they have been on the frontline of COVID-19 management from the beginning of the epidemic. Studies have been carried out in this specific J o u r n a l P r e -p r o o f population to estimate whether the risk of infection is higher in this group than in the general population. In a sample of 316 HCWs in direct contact with COVID-19 patients in a German hospital, the proportion of participants with antibodies against SARS-CoV-2 was 1.6% (Korth J. et al, 2020) . However, in a similar study in a Belgian hospital, that proportion was 12.6% (Martin C. et al, 2020) .

Other prevalence studies have been performed in China and the Netherlands, but they were based on symptomatic HCWs (Lai X. et al, 2020; Kluytmans-van den Bergh M.F.Q., et al, 2020) . In our country, a seroprevalence study was performed on a random sample of 578 participants from a tertiary hospital in Barcelona (Garcia-Basteiro A.L. et al, 2020) . The prevalence in HCWs was found to be 9.3%, higher than the seroprevalence in the general population of Barcelona (6.8%) (Pollan M. et al, 2020) .

The objectives of this study were to determine the seroprevalence of SARS-CoV-2 antibodies in HCWs at a university hospital in Mallorca, Spain, and to examine the potential relationship with onset symptoms and exposure to COVID-19 individuals.

This cross-sectional seroprevalence study was performed between 28 th April 2020 and 11 th June 2020. The target population was all HCWs registered in the Human Resources database of the University Hospital Son Llatzer, which also includes Hospital Joan March, in the island of Mallorca, Spain. The HCWs were classified as: physicians, registrars, nurses, nursing assistants, wardens, and J o u r n a l P r e -p r o o f other healthcare and non-healthcare workers, including psychologists, physiotherapists, optometrists, nutritionists, social workers, administrative staff, and kitchen workers. For the primary analysis, the inclusion criteria required being registered in the human resources database as a hospital worker and giving consent for a blood draw and a nasopharyngeal swab. All external workers who were not in this database and all participants with no serological results were excluded. The participants from the primary study who had also completed a questionnaire collecting information on onset symptoms and exposure to COVID-19 individuals (hospital patients, co-workers or family and friends) were included in the secondary analysis.

The University Hospital Son Llatzer, which includes Joan March Hospital, is the second biggest hospital in Mallorca, with more than 400 hospital beds, and provides health services to a population of around 250 000 (Ministerio de Sanidad). All the participants provided their consent for a blood draw and a nasopharyngeal swab. We obtained approval from the local ethics committee to use the data generated in this study for research purposes (Protocol IB4299/20PI).

An e-mail was sent on 20 th April 2020 to all HCWs, inviting them to participate in this study. After consenting to participate, information on age, sex, and professional category was recorded. A blood draw for immunoglobulin detection and a nasopharyngeal swab for reverse transcription quantitative polymerase chain reaction (RT-qPCR) for the detection of SARS-CoV-2 RNA were obtained J o u r n a l P r e -p r o o f from all the participants, and stored at -80ºC until their analysis. Both procedures were performed by trained nurses using appropriate personal protective equipment. When a positive RT-qPCR result was obtained, the patient was immediately contacted and isolated until obtaining a negative result.

Participants who took both tests were also invited to complete the above mentioned questionnaire online. The manufacturer reported a sensitivity for IgG of 86.4% after 7 days from symptom onset and 100% after 14 days, and a specificity of 99.6%, using RT-PCR as the gold standard. A sensitivity for IgM they reported 85.7% after 7 days from symptom onset and 96.7% after 14 days, and a specificity of 99.6%, using RT-PCR as the gold standard.

All participants with a positive result for IgM, IgG or IgM and IgG antibodies were considered as positive for statistical purposes. Seroprevalence of SARS-CoV-2 antibodies was reported as a percentage and the 95% confidence interval (CI) was estimated using a finite population correction. Results were reported for the total study population and for each of the seven groups studied: physicians, registrars, nurses, nursing assistants, wardens, and other healthcare and non-healthcare workers. Other healthcare workers included psychologists, physiotherapists, optometrists, nutritionists, and social workers; other non-healthcare workers included administrative and management staff and kitchen workers. Categorical variables were expressed as counts and percentages. Continuous variables such as age were expressed as mean and standard deviation (SD).

Comparisons between groups (positive vs negative serological results) were performed using Fisher's exact test (categorical variables) or the independent J o u r n a l P r e -p r o o f Student t-test (continuous variables) after assessing for normality using histograms and the Shapiro-Wilk test.

In April 2020, there were 2805 HCWs in the Human Resources database. Our original database was composed of 2595 participants. After eligibility assessment, a total of 2210 participants were included in the primary analysis ( Figure 1) , with a total response rate of 79%. Mean (SD) age was 44 (10) years and 74% (1637 participants) were women.

Sixty one participants tested positive for SARS-CoV-2 antibodies, a prevalence of 2.8% (95% CI: 2.5-3.1). Two were positive for IgM, three for IgM and IgG, and the remaining participants (56) were positive for IgG. The seroprevalence results according to professional category (Table I) show that registrars, nurses, and wardens were the HCWs with the highest seroprevalence. The five nonhealthcare workers who tested positive were all from the administrative staff.

The mean (SD) age of the 61 participants who tested positive for SARS-CoV-2 antibodies was 42 (11) and 42 were women (69%). There were no statistical differences compared with the participants who had negative results: mean (SD) age was 44 (10) Table II . No statistical comparisons have been performed between the two studied groups because of the low number of events in the positive Ig group. In general, the rate of comorbidities was low in both groups, being cardiovascular disease the more prevalent one. Table III shows the percentage of participants who indicated they had been exposed to COVID-19 individuals. Participants with positive immunoglobulin results had also had more direct exposure to COVID-19 individuals, whether hospital patients, co-workers, or family members.

Finally, 15 of the 25 participants who tested positive for SARS-CoV-2 antibodies experienced COVID-19 compatible symptoms. Figure 2 summarizes the main symptoms experienced, with asthenia, fever, anosmia, and cough as the most common ones.

The findings from this cross-sectional study suggest that the seroprevalence of SARS-CoV-2 antibodies in the HCWs of our university hospital in Mallorca, Spain, is around 2.8%. This seroprevalence appears to be slightly higher than in the general population of the Balearic Islands, which is estimated at 1.8% (Pollan M. et al, 2020) .

There is some evidence that HCWs are at greater risk of SARS-CoV-2 infection.

In a study carried out in China, 4% of all infected individuals were HCWs (Wu Z. et al, 2020) . This percentage was even higher in Los Angeles County in the United States, where positive HCWs represented 9% of all infections (Hartmann S. et al, 2020) . Other countries have also found a higher seroprevalence of SARS-CoV-2 antibodies in HCWs than in the general population. For example, in a cross-sectional study in another region of Spain, seroprevalence in a tertiary Hospital in Barcelona was found to be 9.3%, a higher percentage than in the general population of that region (6.8%) (Pollan M. et al, 2020) .

Furthermore, in London, where the general population seroprevalence was reported to be around 17% (Livemint, 2020), Portland Hospital estimated a HCW seroprevalence of 22% (Khalil A. et al, 2020) . However, other studies have not found differences in the presence of antibodies against SARS-CoV-2 between HCWs and the general population. For instance, in New York, the seroprevalence was around 14%, a figure similar to the seroprevalence found in HCWs from the Northwell Health System (13.7%) (Rosenberg E.S. et al, 2020; Moscola J. et al, 2020) .

In our hospital, nurses, wardens, and registrars were the HCWs with the highest seroprevalence. There is little evidence regarding seroprevalence in wardens and registrars in the literature. This may be because registrars are generally included in the same group as the physicians. However, the small sample of registrars in our study population makes interpretation of this finding difficult. A higher seroprevalence among nurses compared with other HCWs has also been reported. A Chinese study found a higher seroprevalence among nurses compared with physicians (Lai X. et al, 2020) , while in another study conducted J o u r n a l P r e -p r o o f in Los Angeles infections in nurses accounted for almost half of all SARS-CoV-2 infections, although no prevalence was reported (Hartmann S. et al, 2020) .

As expected, in our study, participants with a higher degree of exposure to COVID-19 individuals had higher levels of SARS-CoV-2 antibodies. Exposure to COVID-19 resulted from contact with co-workers, family, friends, and patients, although the relationship between the presence of anti-SARS-CoV-2 antibodies and exposure to patients was not statistically significant (Table III; p=0.10).

However, despite not being statistically significant, a tendency towards a higher degree of exposure to COVID-19 patients was observed in HCWs who tested positive in the immunoglobulin assay (60%) compared with the group of HCWs who tested negative (42%).

With regard to self-reported COVID-19 symptoms in the 25 participants who tested positive for SARS-CoV-2 antibodies, asthenia, fever, cough, and anosmia were the symptoms that appeared in the majority of cases. In a study carried out in two Dutch Hospitals, the main symptoms were also asthenia (defined as general malaise), cough, and fever (Kluytmans-van den Bergh M. F.Q. et al, 2020) . In that study, anosmia was not one of the most common symptoms. However, in a brief report recently published from Emory University School of Medicine (Atlanta, United States), loss of taste and smell was found in 11% of participating HCWs, and fatigue, cough, and nasal congestion were the most common symptoms (Kempker R.R. et al, 2020) . Thus, the symptoms described in our series are similar to those found in other published studies, with the exception of anosmia which was present in 40% of participants, a higher percentage than in the majority of studies.

Our study has several strengths. First, to our knowledge, this is the largest sample-sized SARS-CoV-2 seroprevalence study conducted in HCWs in Spain (Garcia-Basteiro A.L. et al, 2020; Olalla J. et al, 2020; Valdivia A. et al, 2020) .

Other retrospective studies have reported the percentage of HCWs with symptomatic COVID-19 (Suarez-Garcia I. et al, 2020) , but their objective was not the estimation of the seroprevalence in HCWs. Furthermore, in addition to the RT-qPCR and serological tests results, we also provide information on the degree of exposure to COVID-19 individuals and onset symptoms. Another key aspect of this study is the high response rate achieved (almost 80%).

However, our study is not without limitations. First, we could not classify participants into groups according to their degree of exposure (high vs low) to COVID-19 patients because information on the precise location of where some of them, such as wardens and assistant nurses, had been working was not available. Although the response rate in the primary study (seroprevalence and PCR) was high, fewer participants completed the questionnaire (39% of those included in the primary analysis). As a result, only 25 participants with positive serological results were included in the secondary analysis. Another key aspect is that the results of this study should be interpreted in the context of the first wave of the pandemic given that a higher number of individuals are being infected in the Balearic Islands during the current second wave and therefore seroprevalence may vary. Furthermore, participants included at the beginning of the recruitment period may have contracted the infection lately during the study, and then the seroprevalence may be underestimated. There is also a possibility of memory bias when answering the questionnaire. Lastly, there is a possibility that a number of participants may have been infected with SARS-CoV-2, but that by the time this study was performed, their antibody concentrations may have become undetectable, thus testing negative in our study.

Mallorca, Spain, is around 2.8% and is slightly higher in nurses, wardens, and registrars. Study participants with antibodies against SARS-CoV-2 had a higher degree of exposure to COVID-19 individuals than those who tested negative.

We believe it would be advisable to perform further seroprevalence studies during the second wave of the pandemic in our region. J o u r n a l P r e -p r o o f 

Gastrointestinal manifestations of COVID-19: impact on nutrition practices

European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of 29

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

Clinical characteristics of coronavirus disease 2019 in China

COVID-19) infections among healthcare workers

Loss of smell and taste among healthcare personnel screened for coronavirus 2019

SARS-CoV-2-specific antibody detection in healthcare workers in a UK maternity hospital: correlation with SARS-CoV-2 RT-PCR results

Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease

in 2 Dutch hospitals during an early phase of the pandemic

SARS-CoV-2-specific antibody detection in heathcare workers in Germany with direct contact to COVID-19 patients

Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China

Dynamic of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk health care workers and hospital staff

Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Deparment

Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City area

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

Validation and performance comparison of three SARS-CoV-2 antibody assays

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience

Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York

Estimating the burden of SARS-CoV-2 in France

Clinical performance of two SARS-CoV-2 serologic assays

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoC-POP): a population-based study

SARS-CoV-2 infection among healthcare workers in a hospital in Madrid

Caveats in interpreting SARS-CoV-2 IgM + /IgG -antibody profile in asymptomatic health care workers

Ageusia and anosmia, a common sign of COVID-19? doi

World Health Organization. WHO Director-general's opening remark at the media briefing on COVID-19

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention

A novel coronavirus from patients with pneumonia in China

We thank all the personnel from our hospital who participated in the study, as well as all the nurses, physicians and other workers from the occupational health department.J o u r n a l P r e -p r o o f

Tables: Table I